NCT03935022

Brief Summary

Aims of the project

  1. 1.To determine the rice anthocyanin content via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS
  2. 2.To study the oral bioavailability of anthocyanins in healthy volunteers after the intake of a serving (80 g) of black rice (Venere and Artemide varieties).
  3. 3.To determine the plasma biokinetics parameters of rice anthocyanins via spectrophometric determination and high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 17, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 2, 2019

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2019

Completed
Last Updated

April 3, 2020

Status Verified

April 1, 2020

Enrollment Period

2 months

First QC Date

April 17, 2019

Last Update Submit

April 2, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in plasma total anthocyanin detection

    Total anthocyanins will be detected via spectrophometric determination; expressed as μg of catechin per mL of plasma

    0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

  • Changes in plasma Cyanidin-3-O-glucoside detection

    Cyanidin-3-O-glucoside will be detected via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS) in plasma; expressed nM (nano molar) in plasma

    0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

Secondary Outcomes (2)

  • Changes in plasma antioxidant capacity ABTS

    0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

  • Changes in plasma antioxidant capacity DPPH

    0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

Study Arms (3)

Black rice Venere

EXPERIMENTAL

Healthy volunteers will receive the black rice Venere in a cross-over randomized clinical trial (after 7 days wash-out).

Other: Rice

Black rice Artemide

EXPERIMENTAL

Healthy volunteers will receive the black rice Artemide in a cross-over randomized clinical trial (after 7 days wash-out).

Other: Rice

Complete white rice

SHAM COMPARATOR

Healthy volunteers will receive the complete white rice in a cross-over randomized clinical trial (after 7 days wash-out).

Other: Rice

Interventions

RiceOTHER

Each group will randomly receive, during three different experimental days, one of the following treatments by different allocation sequences: 1. 80g of black rice Venere (Group A) 2. 80g of black rice Artemide (Group B) 3. 80g of brown rice (Group C) The three treatments will be separated by a 7 day wash-out period. After an overnight fast, volunteers will consume the rice serving within 10-15 min, immediately after the first basal blood collection at 8:00 a.m. (baseline). Other blood withdrawals will be carried out a 0.5, 1.0, 2.0 and 3.0 h after rice administration.

Black rice ArtemideBlack rice VenereComplete white rice

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy status
  • Age: 18-45
  • Normal weight (BMI 18.5-24.9) who voluntarily accept to join the study, after informed consent.

You may not qualify if:

  • \<18 Years;
  • Pregnancy and lactation;
  • Systemic disorders;
  • Dietary supplements intake (vitamins, antioxidants, botanicals, phytochemicals)
  • Abnormal hematological parameters;
  • Heavy smoking and alcohol drinking;
  • High-intensity physical activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marcello Iriti

Milan, MI, 20133, Italy

Location

Related Publications (5)

  • Garcia-Conesa MT, Chambers K, Combet E, Pinto P, Garcia-Aloy M, Andres-Lacueva C, de Pascual-Teresa S, Mena P, Konic Ristic A, Hollands WJ, Kroon PA, Rodriguez-Mateos A, Istas G, Kontogiorgis CA, Rai DK, Gibney ER, Morand C, Espin JC, Gonzalez-Sarrias A. Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses. Int J Mol Sci. 2018 Feb 28;19(3):694. doi: 10.3390/ijms19030694.

    PMID: 29495642BACKGROUND
  • Krga I, Milenkovic D. Anthocyanins: From Sources and Bioavailability to Cardiovascular-Health Benefits and Molecular Mechanisms of Action. J Agric Food Chem. 2019 Feb 20;67(7):1771-1783. doi: 10.1021/acs.jafc.8b06737. Epub 2019 Feb 8.

    PMID: 30698008BACKGROUND
  • Ciulu M, Cadiz-Gurrea ML, Segura-Carretero A. Extraction and Analysis of Phenolic Compounds in Rice: A Review. Molecules. 2018 Nov 6;23(11):2890. doi: 10.3390/molecules23112890.

    PMID: 30404149BACKGROUND
  • Dias ALS, Pachikian B, Larondelle Y, Quetin-Leclercq J. Recent advances on bioactivities of black rice. Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):470-476. doi: 10.1097/MCO.0000000000000417.

    PMID: 28858891BACKGROUND
  • Van Hung P. Phenolic Compounds of Cereals and Their Antioxidant Capacity. Crit Rev Food Sci Nutr. 2016;56(1):25-35. doi: 10.1080/10408398.2012.708909.

    PMID: 25075608BACKGROUND

Study Officials

  • Marcello Iriti

    University of Milan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 17, 2019

First Posted

May 2, 2019

Study Start

March 6, 2019

Primary Completion

May 15, 2019

Study Completion

July 21, 2019

Last Updated

April 3, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations